Skip to main content
. 2003 Apr;55(4):360–367. doi: 10.1046/j.1365-2125.2003.01780.x

Figure 3.

Figure 3

Interferon-alpha (IFN-α) 2b concentration–time profiles in the initial single-dose (a) and final multiple-dose (b) studies in patients treated with IFN-α 2b plus ribavirin combination therapy. —, Patients with sustained virological response; —, those with virological response during treatment, but without sustained virological response after cessation of treatment; ·····, patients without virological response throughout the study period.